Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

Ascentage Pharma Group International (($HK:6855)) announced an update on their ongoing clinical study. Study Overview: Ascentage Pharma Group ...

To understand treatment patterns and preferences, a series of expert-led Case-Based Roundtable events were conducted over the ...

Kirstin Czernek and her husband share four kids, three of whom were adopted. Their two younger children have Down syndrome ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

The Edmonton Oilers’ anthem singer who became a fan favourite for belting out O Canada in the stands with fans says he’s ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

When Emily Coiro was 3 years old, her beloved grandmother was diagnosed with leukemia. About 25 years later ... Coiro was assured that she was the match, and she immediately began the testing and ...

Despite major advances in immunotherapy—including the 2025 Nobel Prize in Physiology or Medicine recognizing advances in peripheral immune tolerance—progress against leukemia has remained limited.

Then-4-year-old Bryn Ailinger loved dancing and gymnastics and was “always running around.” Suddenly in April 2024, she started complaining that her legs hurt. “It progressed over a two-week period to ...